Personal tools

You are here: Home / Events / "The 90-Day Evolution of COVID-19 Diagnostic Testing: Implications for Public Health and Public Policy in California"

"The 90-Day Evolution of COVID-19 Diagnostic Testing: Implications for Public Health and Public Policy in California"

Dr. Nam K. Tran, UC Davis Medical Center
  • "The 90-Day Evolution of COVID-19 Diagnostic Testing: Implications for Public Health and Public Policy in California"
  • 2020-06-23T12:00:00-07:00
  • 2020-06-23T13:00:00-07:00
  • Dr. Nam K. Tran, UC Davis Medical Center
When
Jun 23, 2020 from 12:00 PM to 01:00 PM (America/Los_Angeles / UTC-700)
Where
Webinar
Contact Name
Contact Phone
19164455161
Web
Visit external website
Add event to calendar
iCal

 

* In light of the concerns regarding COVID-19, this talk will be given as a webinar. *  

 

The COVID-19 Pandemic has created many unique health care challenges across the nation. Diagnostic testing of SARS-CoV-2 remains the primary means for diagnosing COVID-19. For this presentation, we will discuss how hospital laboratories respond to COVID-19, barriers to current testing demands, the role of serology testing, and efforts by the medical community to educate the general public. Additionally, this presentation will highlight potential solutions to overcome testing barriers, where testing needs to go today, where we will be for Fall 2020, and how these considerations influence California public health policy. 

Dr. Nam K. Tran received his B.S. degree in Biochemistry and Molecular Biology in 2003, from UC Davis. In 2008, he completed his Ph.D. in Comparative Pathology from UC Davis. He served as a Tran Photopostdoctoral scholar at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) UC Davis Point-of-Care (POC) Technologies Center from 2009-2011. During this time he also completed a M.S. in Pharmacology and Toxicology. From 2011-2013, he was a National Institutes of Health Mentored Clinical Research Training Program (MCRTP) Scholar. This scholarship was followed by a National Heart Lung and Blood Institute (NHLBI) Emergency Medicine K12 Career Award (2014) focusing on the development of translational physiologically based pharmacokinetic (PBPK) models for antimicrobial therapy in critically ill children.

Currently, Dr. Tran serves as Associate Clinical Professor and Director of Clinical Chemistry, Special Chemistry, Toxicology, POC Testing, and the Specimen and Reporting Center (SARC). He is board certified in clinical chemistry (high complexity laboratory director certification) through the American Board of Bioanalysis (ABB). Dr. Tran also serves as the instructor of record for the resident physician and medical student Clinical Chemistry rotations.

Dr. Tran’s is an expert in POC testing and focuses his research on the development and application of novel medical tests in high-risk populations such as severely burned patients. This role is exemplified by his seminal work in POC testing in severely burned patient using molecular techniques and novel biomarkers of injury, as well as transformative studies applying new models of glucose monitoring and hemoglobin testing in critically ill.

In light of the community concerns regarding COVID-19, this talk will be given as a webinar. The link will be provided on Monday, June 22nd to those that have registered by 5:00 pm on Friday, June 19th. 

 

Please click here to view the PowerPoint presentation.

Please click here to view the video.

Please click here for a print friendly flyer.

PLEASE CLICK HERE TO REGISTER

This is Sliced Diazo Plone Theme